321 related articles for article (PubMed ID: 16897187)
1. The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage.
Masuda Y; Futamura M; Kamino H; Nakamura Y; Kitamura N; Ohnishi S; Miyamoto Y; Ichikawa H; Ohta T; Ohki M; Kiyono T; Egami H; Baba H; Arakawa H
J Hum Genet; 2006; 51(8):652-664. PubMed ID: 16897187
[TBL] [Abstract][Full Text] [Related]
2. DFNA5: hearing impairment exon instead of hearing impairment gene?
Van Laer L; Vrijens K; Thys S; Van Tendeloo VF; Smith RJ; Van Bockstaele DR; Timmermans JP; Van Camp G
J Med Genet; 2004 Jun; 41(6):401-6. PubMed ID: 15173223
[TBL] [Abstract][Full Text] [Related]
3. The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein.
Op de Beeck K; Van Camp G; Thys S; Cools N; Callebaut I; Vrijens K; Van Nassauw L; Van Tendeloo VF; Timmermans JP; Van Laer L
Eur J Hum Genet; 2011 Sep; 19(9):965-73. PubMed ID: 21522185
[TBL] [Abstract][Full Text] [Related]
4. A 3-nucleotide deletion in the polypyrimidine tract of intron 7 of the DFNA5 gene causes nonsyndromic hearing impairment in a Chinese family.
Yu C; Meng X; Zhang S; Zhao G; Hu L; Kong X
Genomics; 2003 Nov; 82(5):575-9. PubMed ID: 14559215
[TBL] [Abstract][Full Text] [Related]
5. In CEM cells the autosomal deafness gene dfna5 is regulated by glucocorticoids and forskolin.
Webb MS; Miller AL; Thompson EB
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):15-21. PubMed ID: 17616391
[TBL] [Abstract][Full Text] [Related]
6. DFNA5, a gene involved in hearing loss and cancer: a review.
de Beeck KO; Van Laer L; Van Camp G
Ann Otol Rhinol Laryngol; 2012 Mar; 121(3):197-207. PubMed ID: 22530481
[TBL] [Abstract][Full Text] [Related]
7. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
8. ECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damage.
Patel H; Sheikh MS; Huang Y
Cell Death Dis; 2020 Jul; 11(7):543. PubMed ID: 32681017
[TBL] [Abstract][Full Text] [Related]
9. A novel DFNA5 mutation, IVS8+4 A>G, in the splice donor site of intron 8 causes late-onset non-syndromic hearing loss in a Chinese family.
Cheng J; Han DY; Dai P; Sun HJ; Tao R; Sun Q; Yan D; Qin W; Wang HY; Ouyang XM; Yang SZ; Cao JY; Feng GY; Du LL; Zhang YZ; Zhai SQ; Yang WY; Liu XZ; He L; Yuan HJ
Clin Genet; 2007 Nov; 72(5):471-7. PubMed ID: 17868390
[TBL] [Abstract][Full Text] [Related]
10. DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells.
Lage H; Helmbach H; Grottke C; Dietel M; Schadendorf D
FEBS Lett; 2001 Apr; 494(1-2):54-9. PubMed ID: 11297734
[TBL] [Abstract][Full Text] [Related]
11. IVS8+1 DelG, a Novel Splice Site Mutation Causing DFNA5 Deafness in a Chinese Family.
Li-Yang MN; Shen XF; Wei QJ; Yao J; Lu YJ; Cao X; Xing GQ
Chin Med J (Engl); 2015 Sep; 128(18):2510-5. PubMed ID: 26365971
[TBL] [Abstract][Full Text] [Related]
12. A DFNA5 mutation identified in Japanese families with autosomal dominant hereditary hearing loss.
Nishio A; Noguchi Y; Sato T; Naruse TK; Kimura A; Takagi A; Kitamura K
Ann Hum Genet; 2014 Mar; 78(2):83-91. PubMed ID: 24506266
[TBL] [Abstract][Full Text] [Related]
13. 5-Lipoxygenase is a direct p53 target gene in humans.
Gilbert B; Ahmad K; Roos J; Lehmann C; Chiba T; Ulrich-Rückert S; Smeenk L; van Heeringen S; Maier TJ; Groner B; Steinhilber D
Biochim Biophys Acta; 2015 Aug; 1849(8):1003-16. PubMed ID: 26070487
[TBL] [Abstract][Full Text] [Related]
14. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.
Hur J; Bell DW; Dean KL; Coser KR; Hilario PC; Okimoto RA; Tobey EM; Smith SL; Isselbacher KJ; Shioda T
Cancer Res; 2006 Oct; 66(20):10153-61. PubMed ID: 17047080
[TBL] [Abstract][Full Text] [Related]
15. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
16. AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression.
Li J; Jiang P; Robinson M; Lawrence TS; Sun Y
Carcinogenesis; 2003 May; 24(5):827-34. PubMed ID: 12771025
[TBL] [Abstract][Full Text] [Related]
17. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma.
Kim MS; Chang X; Yamashita K; Nagpal JK; Baek JH; Wu G; Trink B; Ratovitski EA; Mori M; Sidransky D
Oncogene; 2008 Jun; 27(25):3624-34. PubMed ID: 18223688
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death.
Rogers C; Fernandes-Alnemri T; Mayes L; Alnemri D; Cingolani G; Alnemri ES
Nat Commun; 2017 Jan; 8():14128. PubMed ID: 28045099
[TBL] [Abstract][Full Text] [Related]
19. Role of p53 serine 46 in p53 target gene regulation.
Smeenk L; van Heeringen SJ; Koeppel M; Gilbert B; Janssen-Megens E; Stunnenberg HG; Lohrum M
PLoS One; 2011 Mar; 6(3):e17574. PubMed ID: 21394211
[TBL] [Abstract][Full Text] [Related]
20. p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis.
Kho PS; Wang Z; Zhuang L; Li Y; Chew JL; Ng HH; Liu ET; Yu Q
J Biol Chem; 2004 May; 279(20):21183-92. PubMed ID: 15016801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
